SCHEMBL17808987

SCHEMBL17808987

c1ccc2c(c1)-c1ccccc1C21c2ccccc2C2(c3ccccc3-c3ccccc32)c2cc(-c3cc(-n4c5ccccc5c5ccccc54)cc(-n4c5ccccc5c5ccccc54)c3)ccc21

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ PDK2 Q15119 7/20 0.32
▸ DUSP3 P51452 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17692385 0.93 KDM4E (0.40) KDM4EATML3MBTL1PDK2
SCHEMBL17808983 0.90 L3MBTL1 (0.41) KDM4EATML3MBTL1PDK2DUSP3
SCHEMBL13355910 0.90 KDM4E (0.43) KDM4EATML3MBTL1PDK2DUSP3
SCHEMBL13355935 0.90 KDM4E (0.43) KDM4EATML3MBTL1PDK2DUSP3
SCHEMBL17808988 0.89 KDM4E (0.40) KDM4EATML3MBTL1PDK2DUSP3
SCHEMBL20086970 0.86 L3MBTL1 (0.47) KDM4EATML3MBTL1PDK2
SCHEMBL14595509 0.86 PDK2 (0.40) KDM4EATML3MBTL1PDK2
SCHEMBL17692382 0.85 KDM4E (0.39) KDM4EATML3MBTL1PDK2
SCHEMBL12958150 0.84 KDM4E (0.42) KDM4EATML3MBTL1PDK2DUSP3
SCHEMBL17929483 0.84 KDM4E (0.35) KDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10205100-B2 Anthracene compound, light-emitting element, light-emitting device, electronic appliance, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2019-02-12 — — US disclosed
US-20170025616-A1 ANTHRACENE COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2017-01-26 — — US disclosed
US-20170025616-A1 ANTHRACENE COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LAB (JP) 2017-01-26 — — US disclosed
US-9478749-B2 Anthracene compound, light-emitting element, light-emitting device, electronic appliance, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-10-25 — — US disclosed
US-9478749-B2 Anthracene compound, light-emitting element, light-emitting device, electronic appliance, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-10-25 — — US disclosed
US-20160163991-A1 ANTHRACENE COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-06-09 — — US disclosed
US-20160163991-A1 ANTHRACENE COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10205100-B2 Anthracene compound, light-emitting element, light-emitting device, electronic appliance, and lighting device CCNT1, ESR1, AP2A1 KDM4E 3095/4885ATM 284/4885L3MBTL1 774/4885
US-20160163991-A1 ANTHRACENE COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE CCNT1, ESR1, AP2A1 KDM4E 3095/4885ATM 284/4885L3MBTL1 774/4885
US-20170025616-A1 ANTHRACENE COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE CCNT1, ESR1, AP2A1 KDM4E 3095/4885ATM 284/4885L3MBTL1 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback